Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Cradle Genomics
AddedFeb 15, 2024
UpdatedJun 18, 2026
Cradle Genomics

Cradle Genomics

Series A

Cradle Genomics: Transforming prenatal care with comprehensive early-stage NIPT solutions.

HQ
San Diego, CA, US
Founded
2018
Overview
Compare
Fundraising
Employees

Cradle Genomics' mission is to provide knowledge that helps every pregnancy by transforming non-invasive prenatal testing (NIPT). They offer comprehensive fetal genetic analysis and pregnancy health screening solutions at the earliest stages of pregnancy, focusing on improving prenatal care.

Cradle Genomics has made significant strides in the field of prenatal testing, offering advanced NIPT solutions that provide detailed genetic insights. Their work has had a substantial impact on early pregnancy health management, contributing to better outcomes for expectant mothers and their babies.

Cradle Genomics - Similar Companies

Cellscape logo

Cellscape

Invitae logo

Invitae

invitae.com

Nest Genomics logo

Nest Genomics

nestgenomics.com

Genomic Prediction logo

Genomic Prediction

Natera logo

Natera

natera.com

Luna Genetics logo

Luna Genetics

Pathway Genomics logo

Pathway Genomics

Fortuna Genomics logo

Fortuna Genomics

fortuna.bio

Pacgenomics logo

Pacgenomics

pacgenomics.com

Bluestar Genomics logo

Bluestar Genomics

23andMe logo

23andMe

23andme.com

Nucleus logo

Nucleus

Genome Insight logo

Genome Insight

GenomeNext logo

GenomeNext

Fulgent Genetics logo

Fulgent Genetics

Cradle Genomics - Quick Facts

Who are Cradle Genomics' competitors?

Companies similar to Cradle Genomics include Cellscape, Invitae, Nest Genomics and Genomic Prediction.

When was Cradle Genomics founded?

Cradle Genomics was founded in 2018.

Where is Cradle Genomics' headquarters located?

Cradle Genomics' headquarters is located in San Diego, CA, US.

When was Cradle Genomics' last funding round?

Cradle Genomics' most recent funding round was for $6M (USD) in February 2020.

How much has Cradle Genomics raised to-date?

As of Feb 19, 2020, Cradle Genomics has raised a total of $23.1M (USD).

How many employees does Cradle Genomics have?

Cradle Genomics has 34 employees as of Feb 4, 2024.

Cradle Genomics - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Consumers
Main Product
  • Genetic Testing
  • Prenatal Testing
Tags
  • Healthcare
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software